close
close

Financial comparison: Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and Modular Medical (NASDAQ:MODD)


Modular Medical (NASDAQ:MODD – Get Free Report) and Health Sciences Acquisitions Co. 2 ( NASDAQ:HSAQ – Get Free Report ) are small-cap healthcare stocks, but which is the better investment? We’ll compare these two companies based on their earnings strength, profitability, analyst recommendations, valuation, institutional ownership, dividends, and risk.

Risk and volatility

Modular Medical has a beta of 0.52, which means the company’s stock price is 48% less volatile than the S&P 500. For comparison, Health Sciences Acquisitions Co. 2 has a beta of 0.09, which means its stock price is 91% less volatile than the S&P 500.

Profitability

The table below compares Modular Medical and Health Sciences Acquisitions Co.’s net margins. 2, return on equity and return on assets.

Net margins Return on capital Return on assets
Modular medical Not applicable -235.93% -180.37%
Health Sciences Acquisitions Co. 2 Not applicable Not applicable -2.38%

Earnings and valuation

The table below compares Modular Medical and Health Sciences Acquisitions Co.’s revenue, earnings per share and valuation. 2.

Gross revenue Price to sales ratio Net income Earnings per share Price-to-earnings ratio
Modular medical Not applicable Not applicable – $13.88 million ($0.97) -1.75
Health Sciences Acquisitions Co. 2 Not applicable Not applicable -$380,000.00 Not applicable Not applicable

Analyst recommendations

Below is a summary of Modular Medical and Health Sciences Acquisitions Co.’s latest ratings and recommendations. 2, posted by MarketBeat.

Sell ​​ratings Keep your grades up Buy Ratings Strong purchasing ratings Assessment result
Modular medical 0 0 2 0 3.00
Health Sciences Acquisitions Co. 2 0 0 0 0 Not applicable

Modular Medical currently has a consensus price target of $4.25, indicating a potential upside of 150.00%. Given Modular Medical’s likely superior outperformance, research analysts clearly believe that Modular Medical is preferable to Health Sciences Acquisitions Co. 2.

Insider and institutional ownership

27.5% of Modular Medical shares are in the hands of institutional investors. For comparison, 89.7% of Health Sciences Acquisitions Co. shares. 2 is held by institutional investors. 32.3% of Modular Medical shares are owned by company insiders. For comparison, 21.9% of Health Sciences Acquisitions Co. shares. 2 is in the possession of persons having access to confidential information. Strong institutional ownership indicates that equity funds, hedge funds and large fund managers believe the stock will outperform the market over the long term.

About modular medicine

(Get the free report)

Modular Medical, Inc. operates as a development stage medical device company. He focuses on the design, development and commercialization of insulin pumps. Offers MODD1, a two-piece diabetic patch pump. The company was founded in 1998 and is headquartered in San Diego, California.

About Health Sciences Acquisitions Co. 2

(Get the free report)

Health Sciences Acquisitions Corporation 2 has no significant operations. Intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or related business combination with one or more biopharmaceutical and medical technology companies in North America or Europe. Health Sciences Acquisitions Corporation 2 was founded in 2020 and is headquartered in New York.



Receive modular medical journal news and ratings – Enter your email address below to receive a daily concise summary of the latest news and analyst ratings for Modular Medical and related companies with MarketBeat.com’s FREE daily email newsletter.